IL6 and type 2 diabetes mellitus: The endpoints for the first one were CRP, TAC, MDA, NO, and GSH among individuals with T2DM [56], while the studied outcomes for the other one were TNF-α, CRP, IL-6, and NO among subjects with diabetes [59].